Explore groundbreaking studies, clinical trial updates, and emerging technologies shaping the future of cancer treatment.
Explore the groundbreaking Phase I clinical trial of (131)I-labeled CIGB-M3 antibody fragment for targeted colorectal cancer treatment using radioimmunotheranostics.